Global Tumor Ablation Market - Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Tumor Ablation Market, By Type (Tumor Ablation Systems, Image Guidance Products and Accessories), Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer and Others), Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and Other Technologies), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation and Surgical Ablation), End User (Hospitals, Oncology Clinics and Others), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa) Industry Trends and Forecast to 2028.

Tumor Ablation Market Market Analysis and Insights : Global Tumor Ablation Market

The tumor ablation market is expected to witness market growth at a rate of 12.95% in the forecast period of 2021 to 2028. Data Bridge Market Research report on tumor ablation market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the demand for safer therapeutic options is escalating the growth of tumor ablation market.

Tumor ablation is known to be a minimally invasive image-guided technique that is utilized in the treatment of tumors in the liver, lung, kidney, bone, and soft tissue. It is considered a first-line treatment for patients with small hepatocellular carcinomas or benign tumors in the liver.

Major factors that are expected to boost the growth of the tumor ablation market in the forecast period are the rise in the aging population around the world. Furthermore, the technological developments in the ablation devices are further estimated to cushion the growth of the tumor ablation market. On the other hand, the price of containment measures taken by several governments is further projected to impede the growth of the tumor ablation market in the timeline period.

In addition, the rise in the possible prospects offered by the advancing countries will further provide potential opportunities for the growth of the tumor ablation market in the coming years. However, the strict regulatory guidelines leading to significant rise in the development period of product launches which might further challenge the growth of the tumor ablation market in the near future.

This tumor ablation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tumor ablation market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Global Tumor Ablation Market Scope and Market Size

The tumor ablation market is segmented on the basis of type, cancer type, technology, mode of treatment and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

  • On the basis of type, the tumor ablation market is segmented into Tumor Ablation Systems, Image Guidance Products and Accessories.
  • On the basis of cancer type, the tumor ablation market is segmented into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others.
  • On the basis of technology, the tumor ablation market is segmented into radiofrequency ablation, microwave ablation, cryoablation and other technologies.
  • On the basis of mode of treatment, the tumor ablation market is segmented into percutaneous ablation, laparoscopic ablation, surgical ablation.
  • On the basis of end user, the tumor ablation market is segmented into hospitals, oncology clinics, others.

Tumor Ablation Market Country Level Analysis

The tumor ablation market is analyzed, and market size insights and trends are provided by country, type, cancer type, technology, mode of treatment and end user as referenced above.      

The countries covered in the tumor ablation market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tumor ablation market due to the government support for quality healthcare. Furthermore, the increase in the purchasing power parity will further boost the growth of the tumor ablation market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the tumor ablation market due to the rise in the patient population. Moreover, the occurrence of major healthcare providers in rapidly advancing countries is further anticipated to propel the growth of the tumor ablation market in the region in the coming years.

The country section of the tumor ablation market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The tumor ablation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the tumor ablation market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the tumor ablation market. The data is available for the historic period 2011-2019.

Competitive Landscape and Tumor Ablation Market Share Analysis

The tumor ablation market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the tumor ablation market.

The major players covered in the tumor ablation market report are AngioDynamics, Boston Scientific Corporation, EDAP TMS, HealthTronics, Inc., Medtronic, Misonix, Medical Devices Business Services, Inc., Sonacare Medical, Biotronik, Inc., Erbe Elektromedizin GmbH, Smith & Nephew, CONMED Corporation, MERMAID MEDICAL A/S, Integra LifeSciences Corporation, BTG International Ltd, Abbott, BVM Medical Limited, COMSOL INC., Cortex Technology, CooperSurgical, Inc. and AtriCure, Inc among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Tumor Ablation Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE  GLOBAL TUMOR ABLATION MARKET

TABLE 1 GLOBAL TUMOR ABLATION MARKET, BY TYPE, 2015– 2024 (USD MILLION TABLE 2 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 4 GLOBAL IMAGE GUIDANCE PRODUCT MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 5 GLOBAL ACCESSORIES MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 6 GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024(USD MILLION) TABLE 7 GLOBAL TUMOR ABLATION MARKET, LIVER CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 8 GLOBAL TUMOR ABLATION MARKET, BRAIN CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 9 GLOBAL TUMOR ABLATION MARKET, LUNG CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 10 GLOBAL TUMOR ABLATION MARKET, BONE CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 11 GLOBAL TUMOR ABLATION MARKET, KIDNEY CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 GLOBAL TUMOR ABLATION MARKET, PANCREATIC CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL TUMOR ABLATION MARKET, BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL TUMOR ABLATION MARKET,OTHERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL SURGICAL TUMOR ABLATION MARKET, BY REGION, (2015-2024) USD MILLION TABLE 17 GLOBAL LAPAROSCOPIC TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 18 GLOBAL PERCUTANEOUS TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 19 GLOBAL TUMOR ABLATION MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HOSPITALS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 21 GLOBAL ONCOLOGY CLINICS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 22 GLOBAL OTHERS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 23 GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 27 NORTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 28 NORTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 29 EUROPE TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 30 EUROPE TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 31 EUROPE TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 32 EUROPE TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 33 EUROPE TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 34 ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 35 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 36 ASIA-PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 37 ASIA-PACIFIC TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 38 ASIA-PACIFIC TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 39 SOUTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 41 SOUTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 42 SOUTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 43 SOUTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 44 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 45 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 46 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 47 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 48 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions